Polarbearmeds - Home

Start Saving Now on GLP-1 (Semaglutide)

The active ingredient in Ozempic® and Wegovy®, Semaglutide, is now available as a Health Canada–approved generic in Canada. This means a new era of exceptionally affordable GLP-1 medication is here — no more waiting.

  • ✓Same Active Ingredient: Generic Semaglutide contains the exact same pharmaceutical ingredient as Ozempic® and Wegovy® and meets identical Health Canada standards.
  • ✓Significantly Lower Cost: Save up to 80% compared to U.S. brand-name prices. Real pricing is live on the product page.
  • ✓Order Today: No waitlist, no waiting. A valid prescription is all you need to place your order right now.

Already on the waitlist? Great news — the product has launched. You can now order generic Semaglutide pens directly — no form needed.

Generic Semaglutide Is Now Available

Health Canada–approved · Ships in 3–5 business days

Generic Semaglutide Pens product image

Semaglutide

Generic Semaglutide Pens

$199.99
Buy Now →

Prescription required · Secure checkout

Semaglutide: Affordable Generic Now Available in Canada

The wait is over. Generic Semaglutide is now available in Canada.

Semaglutide is the active ingredient found in brand-name products such as Ozempic® and Wegovy®. You can now access the same effective treatment at a significantly more affordable price through Polar Bear Meds — Health Canada–approved and ready to ship.

Why Generic Semaglutide Is a Smart Choice

With the patent expiry now complete, multiple manufacturers have entered the market. This competition has driven prices down dramatically. Generic Semaglutide meets the same Health Canada safety, quality, and efficacy standards as the brand-name version — at a fraction of the cost.

Frequently Asked Questions

Absolutely. Generic medications are not "knock-offs." They are strictly regulated by Health Canada and must meet the same rigorous standards as the brand-name drugs.
To be authorized for sale, the generic must:

  • Contain the exact same active pharmaceutical ingredient (Semaglutide).
  • Match the strength, dosage, and form of the brand.
  • Be proven to have the same therapeutic effect (be bioequivalent).
  • Meet the exact same safety, quality, and manufacturing standards.

The government and generic manufacturers follow a pricing framework designed to lower costs. Prices are anticipated to fall in stages as multiple generic options are approved and enter the market, increasing competition and maximizing savings for patients.

We are expecting initial availability to begin in early 2026 following the expiry of data protection. Prices will likely fall in stages throughout the year. Please note that availability might be limited or sporadic during the initial launch as manufacturers scale up production to meet high demand.